Company / SG&A Expense
LIXTE BIOTECHNOLOGY HOLDINGS, INC. SG&A Expense History
FY2011-FY2015 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A Expense
$1.3M
FY2015
5-year range
$436.1K / $1.3M
FY2011-FY2015
Trend
+17.5%
vs FY2014
Sector context
Sector data unavailable
Latest sector comparison
What the data says
SG&A Expense has increased for 3 consecutive years, from $436,142 in FY2011 to $1M in FY2015.
Based on SEC 10-K filings.
$1M in FY2015 with a 3-year CAGR of +34.1%.
Increased from $533,449 to $1M over the past 3 years.
SG&A Expense over time
Growth rates
- 3-Year CAGR
- +34.1%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- LIXTE BIOTECHNOLOGY HOLDINGS, INC.'s sg&a expense has grown for 3 consecutive years.
- 3-year CAGR of +34.1%, indicating consistent growth.
- In FY2015, sg&a expense increased 17.5% year-over-year.
Company context
Key Data Points
- Altman Z-Score -11.44 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2015 | $1.3M | +17.5% |
| FY2013 | $1.1M | +105.0% |
| FY2012 | $533.4K | +22.3% |
| FY2011 | $436.1K | - |
As of FY2015 · SEC 10-K · Updated Jun 24, 2026